728945-64-0 Usage
General Description
Anthranilic acid, 4-tert-butyl- (5CI) is a chemical compound with the molecular formula C12H15NO2. It is a derivative of anthranilic acid, a white crystalline solid with a sweet, floral odor. Anthranilic acid, 4-tert-butyl- (5CI) is an aromatic amine that is commonly used in the synthesis of pharmaceuticals and dyes. It is also known for its antimicrobial, anti-inflammatory, and antipyretic properties. The tert-butyl group on the 4-position of the anthranilic acid molecule gives it enhanced stability and solubility, making it a valuable intermediate in the production of various organic compounds. Due to its versatile properties, 4-tert-butyl-anthranilic acid is widely used in the chemical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 728945-64-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,8,9,4 and 5 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 728945-64:
(8*7)+(7*2)+(6*8)+(5*9)+(4*4)+(3*5)+(2*6)+(1*4)=210
210 % 10 = 0
So 728945-64-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H15NO2/c1-11(2,3)7-4-5-8(10(13)14)9(12)6-7/h4-6H,12H2,1-3H3,(H,13,14)
728945-64-0Relevant articles and documents
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
-
Page/Page column 468-469, (2018/11/26)
Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: I
BTK protein kinase inhibitors
-
Page/Page column 52, (2009/05/29)
This application discloses pyridine and pyrimidine compounds according to formula I wherein R1, R2, R3, R4, R5, X1 and A are as described herein which inhibit Btk. The compounds disclosed herein are useful to modulate the activity of Btk and treat diseases associated with excessive Btk activity. The compounds are further useful to treat inflammatory and auto immune diseases associated with aberrant B-cell proliferation such as rheumatoid arthritis. Also disclosed are compositions containing compounds of formula I and at least one carrier, diluent or excipient.
QUINAZOLINONES
-
Page/Page column 98, (2008/06/13)
Disclosed are compounds of formula (I), wherein R, R1, R2, R3, R4, R5, R6, R7, R8, Z1, Z2, Z3, k, and Y1 have the meanings indicated in claim 1. Said compounds can be used for the treatment of tumors, among other things.
